Assignee
DEMUTH HANS-ULRICH
6 granted patents·7 pending applications·76 citations·filing 2002–2012
Top patents by PatentIndex Score
13 records- 0192US8058405B2Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptidesDEMUTH HANS-ULRICH·Filed 2009·Granted Nov 15, 2011·38 cites·28 claims
- 0291US6946480B2Glutaminyl based DPIV inhibitorsDEMUTH HANS-ULRICH·Filed 2002·Granted Sep 20, 2005·34 cites·9 claims
- 0378US8889709B2Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditionsDEMUTH HANS-ULRICH·Filed 2009·Granted Nov 18, 2014·4 cites·37 claims
- 0471US8168199B2Dipeptidyl peptidase IV inhibitors for the treatment of schizophrenia and depressionDEMUTH HANS-ULRICH·Filed 2008·Granted May 1, 2012·0 cites·19 claims
- 0561US8685664B2Use of inhibtors of glutaminyl cyclases for treatment and prevention of diseaseDEMUTH HANS-ULRICH·Filed 2008·Granted Apr 1, 2014·0 cites·16 claims
- 0659US2013116290A1Use of Dipeptidyl Peptidase IV Effectors for Normalizing the Blood Glucose Level in MammalsDEMUTH HANS-ULRICH·Filed 2012·Application pending·0 cites
- 0757US2008182798A1Novel effectors of dipeptidyl peptidase IVDEMUTH HANS-ULRICH·Filed 2006·Application pending·0 cites
- 0856US2005222221A1Method for the improvement of islet signaling in diabetes mellitus and for its preventionDEMUTH HANS-ULRICH·Filed 2003·Application pending·0 cites
- 0955US2006287251A1Combination therapy for glycaemic controlDEMUTH HANS-ULRICH·Filed 2004·Application pending·0 cites
- 1052US9156907B2Diagnostic antibody assayDEMUTH HANS-ULRICH·Filed 2011·Granted Oct 13, 2015·0 cites·50 claims
- 1147US2006194852A1Glutaminyl based DPIV inhibitorsDEMUTH HANS-ULRICH·Filed 2006·Application pending·0 cites
- 1244US2004229848A1Glutaminyl based DP IV-inhibitorsDEMUTH HANS-ULRICH·Filed 2004·Application pending·0 cites
- 1337US2007293426A1Methods for improving islet signaling in diabetes mellitus and for its preventionDEMUTH HANS-ULRICH·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →